Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Income Statement [Abstract] | ||||||
REVENUE | $ 11,432 | $ 5,275 | $ 209,484 | $ 14,482 | $ 265,747 | $ 93,664 |
COST OF GOODS SOLD | 4,058 | 4,143 | 148,701 | 7,840 | 182,519 | 43,762 |
GROSS PROFIT | 7,374 | 1,132 | 60,783 | 6,642 | 83,228 | 49,902 |
SELLING, GENERAL AND ADMINISTRATIVE | ||||||
Research and development | 56,684 | 48,282 | 224,405 | 147,324 | 329,452 | 210,706 |
Professional fees | 94,014 | 247,423 | 538,188 | 573,309 | 818,698 | 268,223 |
Sales and marketing expenses | 165,414 | 260,832 | 570,666 | 498,583 | 1,041,575 | 197,372 |
Share based compensation | 2,625,571 | 3,204,382 | 3,223,674 | 311,919 | ||
General and administrative expenses | 1,083,778 | 1,177,077 | 3,628,337 | 2,292,775 | 3,326,306 | 1,831,170 |
TOTAL SELLING, GENERAL AND ADMINISTRATIVE | 4,025,461 | 1,733,614 | 8,165,978 | 3,511,991 | 8,739,705 | 2,819,390 |
LOSS FROM OPERATIONS | (4,018,087) | (1,732,482) | (8,105,195) | (3,505,349) | (8,656,477) | (2,769,488) |
OTHER INCOME (EXPENSE): | ||||||
Interest expense | (703,232) | (68,357) | (2,589,486) | (182,574) | (467,849) | (29,474) |
Amortization of debt discount | (89,787) | |||||
Loss on disposal of assets | (4,067) | |||||
Other income | 347 | 7,252 | 1,110 | |||
Gain on forgiveness of paycheck protection loan | 112,338 | 112,338 | ||||
Change in fair market value of derivative liabilities | 284,289 | 1,375,048 | ||||
Gain on settlement of derivatives | 201,097 | |||||
Foreign currency transaction gain (loss) | (70) | 924 | (21) | |||
TOTAL OTHER EXPENSE | (418,666) | (68,357) | (1,005,165) | (70,236) | (444,209) | (33,541) |
LOSS BEFORE INCOME TAXES | (4,436,753) | (1,800,839) | (9,110,360) | (3,575,585) | (9,100,686) | (2,803,029) |
PROVISION FOR INCOME TAXES | ||||||
NET LOSS | (4,436,753) | (1,800,839) | (9,110,360) | (3,575,585) | (9,100,686) | (2,803,029) |
OTHER COMPREHENSIVE LOSS | ||||||
Foreign currency translation adjustment | 1,338 | 16 | (3,990) | |||
TOTAL COMPREHENSIVE LOSS | $ (4,435,415) | $ (1,800,839) | $ (9,110,344) | $ (3,575,585) | $ (9,104,676) | $ (2,803,029) |
NET LOSS PER COMMON SHARE | ||||||
Net loss per common share, basic (in Dollars per share) | $ (3.58) | $ (5.18) | $ (10.68) | $ (10.29) | $ (25.22) | $ (8.88) |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING | ||||||
Weighted average number of common shares outstanding, basic (in Shares) | 1,240,094 | 347,333 | 853,133 | 347,333 | 360,944 | 315,529 |
X | ||||||||||
- Definition Gain on forgiveness of paycheck protection loan. No definition available.
|
X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. No definition available.
|
X | ||||||||||
- Definition Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|